Journal Watch
- PDF / 146,359 Bytes
- 12 Pages / 583.276 x 792 pts Page_size
- 38 Downloads / 172 Views
UPDATE
© 2008 Adis Data Information BV. All rights reserved.
Journal Watch Contents 1. Perspectives on Patient-Reported Outcomes: Content Validity and Qualitative Research in a Changing Clinical Trial Environment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191 2. Target Validation to Biomarker Development: Focus on RNA Interference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 192 3. Target Validation and Biomarker Identification in Oncology: The Example of Aurora Kinases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 192 4. Use of Transdermal Drug Formulations in the Elderly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 192 5. The Role of Molecular Markers in Predicting Response to Therapy in Patients with Colorectal Cancer . . . . . . . . . . . . . . . . . . . . . . . 193 6. Interindividual Variability of Methadone Response: Impact of Genetic Polymorphism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193 7. Drug-Induced Urinary Retention: Incidence, Management and Prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193 8. A Systematic Review of Interventions to Improve Medication Taking in Elderly Patients Prescribed Multiple Medications . . . . . . 193 9. Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer: A Need for Improved Modelling to Aid Decision Making . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194 10. Dysglycaemias and Fluoroquinolones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194 11. Facilitation of Drug Evaluation in Children by Population Methods and Modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195 12. Free Drug Metabolic Clearance in Elderly People . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195 13. An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare . . . . . . . . . . . . . . . . . 196 14. Adequacy of Patient Information on Adverse Effects: An Assessment of Patient Information Leaflets in the UK . . . . . . . . . . . . . . . 196 15. Improving Global Monitoring of Vaccine Safety: A Survey of National Centres Participating in the WHO Programme for International Drug Monitoring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
Data Loading...
